Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Why men face higher cancer risks may depend on the country they live in (opens in a new tab)

medicalxpress.com · 2026-09-29

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

  • 3 supported
  • 1 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Three of five check out. One claim the study doesn't address.

  • 3 supported
  • 1 overstated
  • 1 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedMen bear a disproportionately higher burden of cancer even for cancers that are not specific to either sex, and a recent study set out to examine how much of that gap is rooted in biology versus modifiable lifestyle habits and health conditions across populations.View evidenceHide evidence

Why this verdict

The paper supports that it studied male–female incidence gaps for 34 non-sex-specific cancers and quantified the contribution of 11 modifiable lifestyle/health factors. However, at abstract depth the paper does not directly measure or decompose biological causes; it estimates measured modifiable contributors, leaving residual disparity potentially due to many unmeasured factors. Framing the study as examining how much is rooted in biology versus lifestyle/conditions therefore goes beyond the supplied evidence.

1

Study evidence

Pooled sample included 589,766 participants (mean age 56.1 years; 53.5% female) with 70,300 documented non–sex-specific cancer cases.

“This cohort study conducted an individual-level analysis of 3 population-based prospective cohorts in China (Shanghai Men's Health Study and Shanghai Women's Health Study) and the UK (UK Biobank)”
Claim 2 of 5Not coveredThe article says smoking was the single biggest contributor in Shanghai, linked to about 52% of the gap, heavy drinking accounted for another 15.1%, and in the UK obesity, smoking, and type 2 diabetes were the leading measured contributors.View evidenceHide evidence

As statedsmoking about 52%; heavy drinking 15.1%; obesity under 8%; smoking 6.26%; type 2 diabetes 3.51%

Why this verdict

The Shanghai figures are supported: smoking AP 51.75% and heavy alcohol drinking AP 15.10%. The UK obesity and smoking figures are also supported: obesity AP 7.68% and smoking AP 6.26%. However, the claim also says type 2 diabetes was among the leading measured UK contributors and gives 3.51%; that detail is not present in the supplied abstract-depth profile, so the full claim is not fully verifiable at this depth.

1

Study evidence

Pooled sample included 589,766 participants (mean age 56.1 years; 53.5% female) with 70,300 documented non–sex-specific cancer cases.

“This cohort study conducted an individual-level analysis of 3 population-based prospective cohorts in China (Shanghai Men's Health Study and Shanghai Women's Health Study) and the UK (UK Biobank)”
2

Study evidence

In the Chinese cohorts, smoking was the largest individual contributor to the male–female cancer incidence gap.ARD = 111.87 cases per 100,000 person-years (95% CI, 95.38–128.00); AP = 51.75%

“Smoking... and heavy alcohol drinking... were leading contributors”
Claim 3 of 5SupportedIn China, the 11 measured risk factors accounted for 84.4% of the male-female cancer gap, while in the UK they explained 26.2%, leaving nearly 74% of the UK disparity unexplained by the measured lifestyle factors.View evidenceHide evidence

As stated84.4% in China; 26.2% in the UK; nearly 74% unexplained in the UK

Why this verdict

The abstract-level profile reports that the 11 risk factors jointly accounted for 84.44% of the male–female incidence rate difference in the Chinese cohorts and 26.21% in the UK cohort. Describing the remaining roughly 74% in the UK as unexplained by the measured factors follows from the reported attributable proportion. Although this was a headline-prominence claim, it does not appear to outrun the story body as described, which noted substantial unexplained disparity.

1

Study evidence

Pooled sample included 589,766 participants (mean age 56.1 years; 53.5% female) with 70,300 documented non–sex-specific cancer cases.

“This cohort study conducted an individual-level analysis of 3 population-based prospective cohorts in China (Shanghai Men's Health Study and Shanghai Women's Health Study) and the UK (UK Biobank)”
Claim 4 of 5SupportedThe analysis used data from China and the UK, including 134,742 adults from urban Shanghai and 455,024 participants from UK Biobank, and examined 34 non-sex-specific cancer types alongside 11 modifiable risk factors.View evidenceHide evidence

As stated134,742 adults; 455,024 participants; 34 cancer types; 11 risk factors

Why this verdict

The profile reports three prospective cohorts including the Shanghai Men’s/Women’s Health Studies and UK Biobank, with China n=134,742 and UK n=455,024, analyzing 34 non-sex-specific cancer endpoints and 11 baseline risk factors.

1

Study evidence

Pooled sample included 589,766 participants (mean age 56.1 years; 53.5% female) with 70,300 documented non–sex-specific cancer cases.

“This cohort study conducted an individual-level analysis of 3 population-based prospective cohorts in China (Shanghai Men's Health Study and Shanghai Women's Health Study) and the UK (UK Biobank)”
Claim 5 of 5SupportedThe story concludes that the cancer gap between men and women varies heavily from country to country and suggests cancer prevention plans should be customized to fit each population.View evidenceHide evidence

Why this verdict

The paper’s abstract-level conclusion supports population-specific contribution patterns and says reducing sex disparities may require prevention strategies tailored to population contexts. The claim is hedged as a suggestion, which matches the paper’s implication, though the evidence is limited to the Chinese Shanghai cohorts and UK Biobank rather than many countries.

1

Study evidence

Pooled sample included 589,766 participants (mean age 56.1 years; 53.5% female) with 70,300 documented non–sex-specific cancer cases.

“This cohort study conducted an individual-level analysis of 3 population-based prospective cohorts in China (Shanghai Men's Health Study and Shanghai Women's Health Study) and the UK (UK Biobank)”
2

Study evidence

In the Chinese cohorts, smoking was the largest individual contributor to the male–female cancer incidence gap.ARD = 111.87 cases per 100,000 person-years (95% CI, 95.38–128.00); AP = 51.75%

“Smoking... and heavy alcohol drinking... were leading contributors”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Limitation: observational cohort design and attributable estimates do not establish causality.

    The story caveats mention unexplained disparity and future work on environmental or biological factors, but they do not mention that the observational design cannot establish causality.

    From Stratified attributable-risk analysis within population cohorts

  • Limitation: residual confounding and exposure measurement error may affect attributable estimates.

    This interpretation-changing limitation is listed in the profile but is not among the story’s stated caveats.

    From Stratified attributable-risk analysis within population cohorts

  • Limitation: findings may not generalize beyond the Shanghai cohorts and UK Biobank populations.

    The story frames the findings as varying country to country and supporting tailored national prevention, but the supplied caveats do not acknowledge limited generalizability beyond these specific cohorts.

    From Stratified attributable-risk analysis within population cohorts

6 things the story did carry across
  • Study design: individual-level analysis of three population-based prospective cohorts from China and the UK, estimating attributable rate differences and attributable proportions for male–female cancer incidence gaps.
  • Scope: 34 non-sex-specific cancer endpoints and 11 measured modifiable lifestyle factors and health conditions.
  • Main joint finding: the measured factors accounted for 84.44% of the male–female incidence rate difference in the Chinese cohorts and 26.21% in the UK cohort.
  • Individual contributors differed by population: smoking and heavy alcohol drinking led in the Chinese cohorts; obesity and smoking led in the UK cohort.
  • Interpretive conclusion: prevention strategies may need to be tailored to population context.
  • Caveat: a substantial portion of the disparity, especially in the UK, remained unexplained by the measured factors.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataQuantify how much of the male–female gap in incidence of 34 non–sex-specific cancers is attributable to 11 modifiable lifestyle factors and health conditions across three large prospective cohorts (China and UK).Pooled individual-level prospective cohort analysisExpand

In plain English

Individual-level pooled analysis of three population-based prospective cohorts (Shanghai Men’s Health Study, Shanghai Women’s Health Study, UK Biobank) estimating how much of the male–female gap in incidence of 34 non–sex-specific cancers is attributable to a prespecified set of 11 modifiable lifestyle factors and health conditions using attributable rate differences (ARD, cases per 100,000 person-years) and attributable proportion (AP, %).

Key findings

  • Pooled sample included 589,766 participants (mean age 56.1 years; 53.5% female) with 70,300 documented non–sex-specific cancer cases.
  • In the Chinese cohorts (n = 134,742), the joint ARD across the 11 risk factors was 182.52 cases per 100,000 person-years (95% CI, 162.46–202.26), accounting for 84.44% of the male–female incidence rate difference.ARD 182.52 per 100,000 person-years; AP 84.44%
“This cohort study conducted an individual-level analysis of 3 population-based prospective cohorts in China (Shanghai Men's Health Study and Shanghai Women's Health Study) and the UK (UK Biobank)”
2secondary dataCompare the leading individual contributors (e.g., smoking, heavy alcohol drinking, obesity) to the sex disparity in cancer incidence within China vs within the UK, to support population-tailored prevention implications.Stratified attributable-risk analysis within population cohortsExpand

In plain English

Within-cohort comparison of the leading individual modifiable contributors to the male–female cancer incidence gap shows different primary drivers in the Chinese versus UK cohorts. In the Chinese cohorts, smoking and heavy alcohol drinking were the largest individual contributors to the male-female incidence rate difference; in the UK cohort, obesity and smoking were identified as the leading individual contributors. These estimates derive from attributable-rate-difference (ARD) and attributable-proportion (AP) calculations applied separately within each population.

Key findings

  • In the Chinese cohorts, smoking was the largest individual contributor to the male–female cancer incidence gap.ARD = 111.87 cases per 100,000 person-years (95% CI, 95.38–128.00); AP = 51.75%
  • In the Chinese cohorts, heavy alcohol drinking was a leading individual contributor to the male–female cancer incidence gap.ARD = 32.64 cases per 100,000 person-years (95% CI, 24.61–40.43); AP = 15.10%
“Smoking... and heavy alcohol drinking... were leading contributors”
What this piece can’t prove
  • Observational cohort design: associations and attributable estimates do not establish causality.
  • Attributable estimates are based on measured exposures and the analytic framework used; potential residual confounding and exposure measurement error may affect estimates.
  • Analyses are stratified by the two study populations (Shanghai cohorts and UK Biobank); findings may not generalize to other populations or settings beyond these cohorts.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 33 candidate papers

And 27 more candidates considered.